1. The Role of Residual Tumor Resection in Patients with Metastatic Renal Cell Carcinoma and Partial Remission following Immunochemotherapy 
Olaf A. Brinkmann, Michael Semik, Georg Gosherger, Lothar Hertle 
European Urology Supplements 
Volume 6, Issue 10, Pages (May 2007)
DOI: /j.eursup
Copyright © 2007 European Association of Urology Terms and Conditions

2. Fig. 1
Kaplan-Meier survival curves of the study groups treated with immunotherapy (IMT) alone (group A) and with IMT in combination with the excision of residual metastatic lesions (group B).
European Urology Supplements 2007 6, DOI: ( /j.eursup )
Copyright © 2007 European Association of Urology Terms and Conditions

3. Fig. 2
A 62-year-old male with metastatic renal cell carcinoma (mRCC, pT3apN0pM1/G3) and bilateral renal tumors showing a lung metastasis prior to treatment (A) and complete remission after treatment (B). Liver metastasis is shown prior to treatment (C) and after treatment with complete resolution (D). Left lower pole kidney tumor prior to treatment (E) and with partial remission after treatment (F). This lesion was finally resected with organ preservation of the kidney.
European Urology Supplements 2007 6, DOI: ( /j.eursup )
Copyright © 2007 European Association of Urology Terms and Conditions